Representative Josh Gottheimer (D-New Jersey) recently sold shares of Azenta, Inc. (NASDAQ:AZTA). In a filing disclosed on April 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Azenta stock on March 19th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.
Representative Josh Gottheimer also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Visa (NYSE:V) on 3/24/2025.
- Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 3/24/2025.
- Sold $1,001 – $15,000 in shares of Flywire (NASDAQ:FLYW) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Disco (OTCMKTS:DSCSY) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Diageo (NYSE:DEO) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Shopify (NYSE:SHOP) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 3/19/2025.
Azenta Price Performance
Azenta stock opened at $26.71 on Monday. The firm has a market cap of $1.22 billion, a P/E ratio of -8.96 and a beta of 1.66. The stock’s 50 day moving average is $39.42 and its 200 day moving average is $44.72. Azenta, Inc. has a one year low of $25.36 and a one year high of $63.58.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on AZTA. Evercore ISI boosted their price objective on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday, February 6th. Needham & Company LLC increased their price target on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a “hold” rating in a research note on Thursday, February 27th. Finally, Stephens reissued an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd.
Check Out Our Latest Analysis on Azenta
Hedge Funds Weigh In On Azenta
Large investors have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC purchased a new stake in Azenta in the 4th quarter valued at about $47,350,000. Conestoga Capital Advisors LLC lifted its stake in Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock valued at $78,894,000 after purchasing an additional 621,830 shares during the last quarter. Norges Bank purchased a new position in Azenta in the fourth quarter valued at approximately $25,403,000. Schroder Investment Management Group grew its stake in shares of Azenta by 46.7% during the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company’s stock worth $70,183,000 after acquiring an additional 447,292 shares during the period. Finally, Marshall Wace LLP purchased a new stake in Azenta in the 4th quarter worth about $20,469,000. Institutional investors own 99.08% of the company’s stock.
About Representative Gottheimer
Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.
Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.
Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.
Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- How to trade penny stocks: A step-by-step guide
- Is McDonald’s Stock Serving a Value Meal to Investors?
- There Are Different Types of Stock To Invest In
- Walgreens Comeback? Private Equity Circling for a Buyout
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.